The role of cardiac troponins as diagnostic biomarkers of myocardial injury in the context of
acute coronary syndrome (ACS) is well established. Since the initial 1st-generation assays …

Over the past 2 decades, cardiac troponins (cTn) have emerged as the preferred biomarkers
for the noninvasive detection of myocardial injury. In conjunction with typical clinical findings …

Objectives: The aims of this study were to assess the prognostic value of cardiac troponin I
levels, measured with a new high-sensitivity assay, in low-risk patients with stable coronary …

Objective The extent of kidney-dependent clearance of the cardiac damage biomarker
cardiac troponin T (cTnT) is not known. Methods and results We examined clearance of …

Background A pilot study using a novel high-sensitivity cardiac troponin I (hs-cTnI) assay
suggested that cTnI might be released into blood during exercise-induced myocardial …

Objectives: Previous community-based studies have failed to demonstrate an independent
association between OSA and circulating cardiac troponin concentrations, a marker of …

BACKGROUND This study aimed to prospectively advance a rule-out strategy for
functionally significant coronary artery disease (CAD) by use of high-sensitivity cardiac …

BACKGROUND Whether cardiac troponin concentrations are increased by reversible
myocardial ischemia is controversial. Differences in the structure of cardiac troponin I (cTnI) …

Background The cardiac stress for veteran football players during match is considerable. In
this specific elderly population, the kinetics of exercise-induced cardiac troponin I (cTnI) and …

The signs and symptoms of heart failure are frequently unspecific and correlate poorly with
objective indices of cardiac function. Objective assessment of cardiac function by …